San Francisco-based technology startup Illumix just closed a $18 million Series A round of funding, and in a rare move for the Shark Tank star, Mark Cuban contributed.
The company develops platforms for augmented reality (AR) experiences and sees itself as a crucial player in the emerging Web3 and metaverse ecosystems.
"We really think about ourselves as the backbone behind your immersive experiences," said Kirin Sinha, CEO and founder of Illumix.
Historically, those experiences were limited to the gaming and entertainment worlds. Now Illumix has its sights on what it calls "location-based entertainment." Sinha explained that the company wants to bring AR to in-person experiences such as sports games, concerts, and theme parks.
On why Cuban decided to invest, despite his aversion to investing in tech firms, Sinha said he thinks "it really comes down to the scope of this opportunity."
"The idea of the digital and physical worlds coming together has been talked about for some time, but we're really seeing that market timing starting to hit," he added.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
